Literature DB >> 18641281

Sialoadhesin expression in intact degenerating retinas and following transplantation.

Javier Sancho-Pelluz1, Kirsten A Wunderlich, Uwe Rauch, F Javier Romero, Theo van Veen, G Astrid Limb, Paul R Crocker, Maria-Thereza Perez.   

Abstract

PURPOSE: Resident microglial cells normally do not express sialoadhesin (Sn; a sialic acid-binding receptor), whereas recruited inflammatory macrophages have been shown to do so. The expression of Sn was examined in the course of photoreceptor cell degeneration and after transplantation.
METHODS: Sn expression was analyzed in retinas of rd1 and rds mice. For transplantation studies, neonatal (P2) retinal cells derived from GFP mice were injected intraocularly in adult rd1 mice and control mice. Antibodies recognizing different Sn epitopes, CD11b, and MHC-II were used to identify activated microglial cells in intact retinas and 21 days after transplantation.
RESULTS: In rd1 mice, a few CD11b-positive cells were observed in the outer nuclear layer in the central retina at postnatal day (P)11 and in increasing numbers between P12 to P21. In rds mice, CD11b-expressing cells were found from P16 onward. No Sn-expressing cells were observed within the rd1 or rds mouse retinas at any of the ages examined (up to P150). Specific staining was observed only in cells found in the vitreous margin of the retina and in surrounding tissues (sclera, cornea, ciliary body, choroid). After transplantation to normal and rd1 mice, a variable number of Sn-positive cells were detected within the grafts, in the graft-host interface, and in the subretinal space.
CONCLUSIONS: The significant activation of microglia/macrophages observed in the various stages of degeneration in rd1 and rds mouse retinas is not accompanied by Sn expression. However, Sn-expressing cells are observed after transplantation. The occurrence of such cells could be of significance for the integration and long-term survival of retinal grafts, as the expression of Sn could facilitate other phagocytic receptors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18641281     DOI: 10.1167/iovs.08-2117

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  6 in total

1.  Mice with a D190N mutation in the gene encoding rhodopsin: a model for human autosomal-dominant retinitis pigmentosa.

Authors:  Javier Sancho-Pelluz; Joaquin Tosi; Chun-Wei Hsu; Frances Lee; Kyle Wolpert; Mirela R Tabacaru; Jonathan P Greenberg; Stephen H Tsang; Chyuan-Sheng Lin
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

Review 2.  Photoreceptor cell death mechanisms in inherited retinal degeneration.

Authors:  Javier Sancho-Pelluz; Blanca Arango-Gonzalez; Stefan Kustermann; Francisco Javier Romero; Theo van Veen; Eberhart Zrenner; Per Ekström; François Paquet-Durand
Journal:  Mol Neurobiol       Date:  2008-11-04       Impact factor: 5.590

Review 3.  Cell transplantation strategies for retinal repair.

Authors:  E L West; R A Pearson; R E MacLaren; J C Sowden; R R Ali
Journal:  Prog Brain Res       Date:  2009       Impact factor: 2.453

4.  SIGLEC1 (CD169): a marker of active neuroinflammation in the brain but not in the blood of multiple sclerosis patients.

Authors:  Lennard Ostendorf; Philipp Dittert; Robert Biesen; Ankelien Duchow; Victoria Stiglbauer; Klemens Ruprecht; Judith Bellmann-Strobl; Dominik Seelow; Werner Stenzel; Raluca A Niesner; Anja E Hauser; Friedemann Paul; Helena Radbruch
Journal:  Sci Rep       Date:  2021-05-13       Impact factor: 4.379

5.  Neurodegeneration severity can be predicted from early microglia alterations monitored in vivo in a mouse model of chronic glaucoma.

Authors:  Alejandra Bosco; Cesar O Romero; Kevin T Breen; Alexis A Chagovetz; Michael R Steele; Balamurali K Ambati; Monica L Vetter
Journal:  Dis Model Mech       Date:  2015-03-09       Impact factor: 5.758

Review 6.  In vitro Model Systems for Studies Into Retinal Neuroprotection.

Authors:  Yu Zhu; Bowen Cao; Arianna Tolone; Jie Yan; Gustav Christensen; Blanca Arango-Gonzalez; Marius Ueffing; François Paquet-Durand
Journal:  Front Neurosci       Date:  2022-07-07       Impact factor: 5.152

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.